Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analytical and Omics-Based Advances in the Study of Drug-Induced Liver Injury

3 Jun 2021

Abstract excerpt

Drug-induced liver injury (DILI) is a significant clinical issue, affecting 1-1.5 million patients annually, and remains a major challenge during drug development-toxicity and safety concerns are the second-highest reason for drug candidate failure. The future prevalence of DILI can be minimized by developing a greater understanding of the biological mechanisms behind DILI. Both qualitative and quantitative...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug-Induced Hepatotoxicity and Protection
Share to Liver Disease Diagnosis and Treatment
Share to Pharmacogenetics and Drug Metabolism

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34086958
DOI: 10.1093/toxsci/kfab069

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analytical and Omics-Based Advances in the Study of Drug-Induced Liver InjuryPMID 34086958Read ↗

Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity.Semantic proximity Read ↗

Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes.Semantic proximity Read ↗

Biomarkers of drug-induced liver injury: progress and utility in research, medicine, and regulation.Semantic proximity Read ↗

Drug-induced liver injury: a safety review.Semantic proximity Read ↗

Research Progress of Pharmacogenomics in Drug-Induced Liver InjurySemantic proximity Read ↗

Genetic and Epigenetic Basis of Drug-Induced Liver Injury.Semantic proximity Read ↗

Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives.Semantic proximity Read ↗

Toxicogenomics of drug induced liver injury – from mechanistic understanding to early prediction.Semantic proximity Read ↗

Approaches to the study of drug-induced liver injury.Semantic proximity Read ↗

Drug-Induced Liver Injury: Insights from Genetic StudiesSemantic proximity Read ↗

Comprehensive analysis of high-throughput transcriptomics to distinguish drug-induced liver injury (DILI) phenotypes.Semantic proximity Read ↗

Predicting and preventing acute drug-induced liver injury: what's new in 2010?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.